186 related articles for article (PubMed ID: 35072235)
1. Can FMR1 CGG repeat lengths predict the outcome in ICSI cycles?
Cogendez E; Ozkaya E; Eser AÇ; Eken M; Karaman A
Ginekol Pol; 2022; 93(9):735-741. PubMed ID: 35072235
[TBL] [Abstract][Full Text] [Related]
2. Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene.
Schufreider A; McQueen DB; Lee SM; Allon R; Uhler ML; Davie J; Feinberg EC
Hum Reprod; 2015 Nov; 30(11):2686-92. PubMed ID: 26345686
[TBL] [Abstract][Full Text] [Related]
3. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL;
Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350
[TBL] [Abstract][Full Text] [Related]
4. Retrospective study of ovarian reaction and fertility in women with discordant antimullerian hormone and follicle-stimulating hormone/luteinizing hormone ratios during in vitro fertilization.
Wang J; Lv Y; Wang X; Zhu G; Zhao F
J Obstet Gynaecol Res; 2023 Mar; 49(3):966-972. PubMed ID: 36734373
[TBL] [Abstract][Full Text] [Related]
5. Comparing four ovarian reserve markers--associations with ovarian response and live births after assisted reproduction.
Brodin T; Hadziosmanovic N; Berglund L; Olovsson M; Holte J
Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1056-63. PubMed ID: 26184379
[TBL] [Abstract][Full Text] [Related]
6. Serum anti-müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles.
Sahmay S; Demirayak G; Guralp O; Ocal P; Senturk LM; Oral E; Irez T
J Assist Reprod Genet; 2012 Jul; 29(7):589-95. PubMed ID: 22492221
[TBL] [Abstract][Full Text] [Related]
7. Association of skewed X-chromosome inactivation with FMR1 CGG repeat length and anti-Mullerian hormone levels: a cohort study.
Barad DH; Darmon S; Weghofer A; Latham GJ; Filipovic-Sadic ; Wang Q; Kushnir VA; Albertini DF; Gleicher N
Reprod Biol Endocrinol; 2017 Apr; 15(1):34. PubMed ID: 28454580
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone.
Gleicher N; Weghofer A; Barad DH
Fertil Steril; 2009 May; 91(5):1700-6. PubMed ID: 18384775
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
[TBL] [Abstract][Full Text] [Related]
10. Intermediate CGG repeat length at the FMR1 locus is not associated with hormonal indicators of ovarian age.
Kline JK; Kinney AM; Levin B; Brown SA; Hadd AG; Warburton D
Menopause; 2014 Jul; 21(7):740-8. PubMed ID: 24423935
[TBL] [Abstract][Full Text] [Related]
11. [Effects of cystectomy for ovary benign cyst on ovarian reserve and pregnancy outcome of in vitro fertilization-embryo transfer cycle].
Zhang XR; Ding LL; Tang R; Sheng Y; Qin YY; Chen ZJ
Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):180-5. PubMed ID: 27030496
[TBL] [Abstract][Full Text] [Related]
12. What are the likely IVF/ICSI outcomes if there is a discrepancy between serum AMH and FSH levels? A multicenter retrospective study.
Daney de Marcillac F; Pinton A; Guillaume A; Sagot P; Pirrello O; Rongieres C
J Gynecol Obstet Hum Reprod; 2017 Oct; 46(8):629-635. PubMed ID: 28843783
[TBL] [Abstract][Full Text] [Related]
13. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder.
Oudshoorn SC; van Tilborg TC; Eijkemans MJC; Oosterhuis GJE; Friederich J; van Hooff MHA; van Santbrink EJP; Brinkhuis EA; Smeenk JMJ; Kwee J; de Koning CH; Groen H; Lambalk CB; Mol BWJ; Broekmans FJM; Torrance HL;
Hum Reprod; 2017 Dec; 32(12):2506-2514. PubMed ID: 29121269
[TBL] [Abstract][Full Text] [Related]
14. AMH in women with diminished ovarian reserve: potential differences by FMR1 CGG repeat level.
Pastore LM; McMurry TL; Williams CD; Baker VL; Young SL
J Assist Reprod Genet; 2014 Oct; 31(10):1295-301. PubMed ID: 24938362
[TBL] [Abstract][Full Text] [Related]
15. FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve.
Rehnitz J; Alcoba DD; Brum IS; Dietrich JE; Youness B; Hinderhofer K; Messmer B; Freis A; Strowitzki T; Germeyer A
Reprod Biol Endocrinol; 2018 Jul; 16(1):65. PubMed ID: 29981579
[TBL] [Abstract][Full Text] [Related]
16. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
[TBL] [Abstract][Full Text] [Related]
17. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
[TBL] [Abstract][Full Text] [Related]
19. Similar prevalence of expanded CGG repeat lengths in the fragile X mental retardation I gene among infertile women and among women with proven fertility: a prospective study.
De Geyter C; M'Rabet N; De Geyter J; Zürcher S; Moffat R; Bösch N; Zhang H; Heinimann K
Genet Med; 2014 May; 16(5):374-8. PubMed ID: 24113347
[TBL] [Abstract][Full Text] [Related]
20. AMH type II receptor and AMH gene polymorphisms are not associated with ovarian reserve, response, or outcomes in ovarian stimulation.
Cerra C; Newman WG; Tohlob D; Byers H; Horne G; Roberts SA; Mohiyiddeen L
J Assist Reprod Genet; 2016 Aug; 33(8):1085-91. PubMed ID: 27142041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
